Ansell Limited
Ansell Limited (ANN.AX) Stock Competitors & Peer Comparison
See (ANN.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ANN.AX | A$29.94 | +5.02% | 4.2B | 21.67 | A$1.34 | +2.77% |
| RMD.AX | A$33.24 | +3.18% | 47.3B | 22.22 | A$1.46 | +1.00% |
| FPH.AX | A$32.10 | +6.01% | 18.2B | 50.70 | A$0.61 | +1.35% |
| NAN.AX | A$3.87 | +4.59% | 1.1B | 52.57 | A$0.07 | N/A |
| TTX.AX | A$4.28 | -1.38% | 217.3M | -10.70 | -A$0.40 | N/A |
| SDI.AX | A$1.25 | +0.00% | 148.6M | 12.50 | A$0.10 | +2.72% |
| AHC.AX | A$0.35 | +4.48% | 125.5M | 16.75 | A$0.02 | N/A |
| TRJ.AX | A$0.41 | +0.00% | 61M | -40.00 | -A$0.01 | N/A |
| OSX.AX | A$0.01 | +16.67% | 1.9M | -0.60 | -A$0.01 | N/A |
Stock Comparison
ANN.AX vs RMD.AX Comparison April 2026
ANN.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANN.AX stands at 4.2B. In comparison, RMD.AX has a market cap of 47.3B. Regarding current trading prices, ANN.AX is priced at A$29.94, while RMD.AX trades at A$33.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANN.AX currently has a P/E ratio of 21.67, whereas RMD.AX's P/E ratio is 22.22. In terms of profitability, ANN.AX's ROE is +0.07%, compared to RMD.AX's ROE of +0.25%. Regarding short-term risk, ANN.AX is less volatile compared to RMD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for ANN.AX.Check RMD.AX's competition here